Integrin-binding peptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 11, 514 14, 514 15, 514 16, 530317, 530327, 530328, 530329, A61K 3812, C07K 512

Patent

active

059814780

ABSTRACT:
This invention is directed to novel integrin binding peptides. These peptides bind to .alpha..sub.v - of .alpha..sub.5 -containing integrins and can exhibit high binding affinity. They contain one of the following sequence motifs: RX.sub.1 ETX.sub.2 WX.sub.3 [SEQ ID NO: 1] (especially RRETAWA [SEQ ID NO: 8]); RGDGX [SEQ ID NO: 2], in which X is an amino acid with a hydrophobic, aromatic side chain; the double cyclic CX.sub.1 CRGDCX.sub.2 C [SEQ ID NO: 15]; and RLD. The peptides generally exhibit their highest binding affinity when they assume a conformationally stabilized configuration. This invention also provides methods of using these peptides.

REFERENCES:
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4957902 (1990-09-01), Grinnell
patent: 5091176 (1992-02-01), Braatz et al.
patent: 5110920 (1992-05-01), Erlich
patent: 5352667 (1994-10-01), Lider et al.
patent: 5575815 (1996-11-01), Slepian et al.
patent: 5627263 (1997-05-01), Ruoslahti et al.
Koivunen et al. J. of Biological Chem, vol. 268, No. 27, pp. 20205-20210. Sep. 25, 1993.
Caplus on STN. No. 1993:186017. Fukuoka et al. Proc. Natl. Acad. Sci. U.S.A. 89(4). pp. 1189-1193, 1992.
O'Neil et al., "Identification of Novel Peptide Antagonist for GPIIb/IIIa from a Conformationally Constrained Phage Peptide Library", Proteins: Structure, Function, and Genetics, vol. 14 509-515, 1992.
Schulz et al., "Emprirical simialrtiies between amino acid residues", in Principles and Protein Structure, Springer-Verlag, New York 1979, pp. 14-16.
Fischer et al. "Inhibition of Osteoclastic Bone Resorption in Vivo by Echistatin an `Arginyl-Glycyl-Aspartyl` (RGD)-Containing Protien", Endocrinology, vol. 132, No. 3, pp. 1411-1413, 1993.
Brooks et al. "Requirement of Vascular Integrin Alpha V Beta 3 for Angiogenesis", Science, vol. 264, pp. 569-571, 1994.
Gehlsen et al. "Inhibition of Invitro Tumor Cell Invasion by Arg-Gly-Asp Containing Synthetic Peptides", J. of Cell Biol., vol. 106, pp. 925-930, 1988.
Humphries et al. "A Synthetic Peptide from Fibronectin Inhibits Experminetal Metastasis of Murine Melanoma Cells", Science, vol. 233, pp. 467-470, 1986.
Koivunen et al. Phage Libraties Displaying Cyclic Petides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins, Bio/Technology, vol. 13, pp. 265-270, 1995.
Koivunen et al., "Selection of Peptides Binding to the a5B1 Integrin form Phage Display Library." J. Biol. Chem. 268:20205-20210, Sep. 1993.
Peishoff et al., "Investigation of Conformational Specificity at GPIIb/IIIa: Evaluation of Confromationally Constrained RGD Peptides." J. Med. Chem. vol. 35, pp. 3962-3969, 1992.
Yamada, K. "Adehsive Recognition Sequences", J. of Biol. Chem., vol. 266, No. 2, pp. 12806-12812, Jul. 1991.
Rudinger, J. (1976). Peptide Hormones (ed. J.A. Parsons). University Park Press. Baltimore. pp. 1-7.
Koivunen et al., "Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins," Bio/Technology 13:265-270 (1995).
Samanen et al., "Development of a Small RGD Peptide Fibrinogen Receptor Antagonist with Potent Antiaggregatory Activity in Vitro," J. Med. Chem. 34:3114-3125 (1991).
Skubitz et al., "Synthetic Peptides from the Carboxy-terminal Globular Domain of the A Chain of Laminin: Their Ability to Promote Cell Adhesion and Neurite Outgrowth, and Interact with Heparin and the .beta.1 Integrin Subunit," J. Cell Biol. 115:1137-1148 (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Integrin-binding peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Integrin-binding peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin-binding peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1455956

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.